Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease.
about
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoeaVaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoeaVaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirusMechanistic Basis of Antimicrobial Actions of Silver NanoparticlesDirected evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.Towards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coliExperimental infection of healthy volunteers with enterotoxigenic Escherichia coli wild-type strain TW10598 in a hospital ward.Modified heat-stable toxins (hSTa) of enterotoxigenic Escherichia coli lose toxicity but display antigenicity after being genetically fused to heat-labile toxoid LT(R192G).Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.Phenotypic and genotypic characterization of enterotoxigenic Escherichia coli clinical isolates from northern Colombia, South America.Molecular characterization of Enterotoxigenic Escherichia coli strains isolated from diarrheal patients in Korea during 2003-2011Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology.Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin.Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.Clonal relatedness of enterotoxigenic Escherichia coli (ETEC) strains expressing LT and CS17 isolated from children with diarrhoea in La Paz, BoliviaGenotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children.From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine developmentRecent advances in understanding enteric pathogenic Escherichia coli.Vaccines against enterotoxigenic Escherichia coli.Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coliDetection of the CS20 colonization factor antigen in diffuse-adhering Escherichia coli strains.Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.Glucose significantly enhances enterotoxigenic Escherichia coli adherence to intestinal epithelial cells through its effects on heat-labile enterotoxin productionRelationship between heat-labile enterotoxin secretion capacity and virulence in wild type porcine-origin enterotoxigenic Escherichia coli strains.A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phasAntibody against recombinant heat labile enterotoxin B subunit (rLTB) could block LT binding to ganglioside M1 receptorGeneration of high-titer of neutralizing polyclonal antibodies against heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coliCooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli.Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactionsGenotypic characterization of enterotoxigenic Escherichia coli strains causing traveler's diarrhea.The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection.Comparison of the contributions of heat-labile enterotoxin and heat-stable enterotoxin b to the virulence of enterotoxigenic Escherichia coli in F4ac receptor-positive young pigs.Electron Acceptors Induce Secretion of Enterotoxigenic Escherichia coli Heat-Labile Enterotoxin under Anaerobic Conditions through Promotion of GspD Assembly.Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine targetDevelopment of vaccine delivery vehicles based on lactic acid bacteria.Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications.Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.Recent progress toward an enterotoxigenic Escherichia coli vaccine.Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
P2860
Q24201328-1ADD638A-8D29-42B7-BD06-4F69172CFCA5Q24236078-0A0C5590-0475-493B-B04B-1A3CBC941C44Q26995690-41142034-9968-4717-AC44-C03B7F469F3EQ28079834-C726CA87-EA86-458D-B14E-89449E803674Q30155406-ACB68CA3-D15F-464F-A623-172B009A2180Q30277331-A6E0C832-EA02-4703-86E7-38760DF044E5Q30410648-0BBBFA3C-F718-49E6-BA83-72BA99F4C841Q30429806-B65CCFD6-52A5-46B2-BC07-975E9052BFE7Q33578033-CE6CAA1A-12C9-457E-B335-9EE2F833A50FQ33616104-32F7A70B-C3FA-4183-AC4D-DD916A338341Q33632443-37A3E668-02A5-43FB-B886-E30821E16E4FQ33794071-ABB01BD8-EA8F-4C77-ACCB-950D03FE31D7Q33899693-6CC988AC-74A0-4E30-ACB3-AAAFAA6B6595Q33963134-35DE04F6-44B8-482A-91FE-262B1E6B86CFQ34090926-33F3C6DE-308C-4C24-86E8-56333504F370Q34120382-1983CD6B-9FE4-4709-803A-CF4A780F1E59Q34171594-BCD6DE90-D49C-4AA7-B657-687F21D8D5FAQ34375210-C3837897-4A00-4A28-BC8B-0A13D7F118A0Q34594874-F1E798C7-B8FE-41C2-B9D6-8A02993D9AF9Q34990310-94EEF984-EEEC-45BD-BAFF-D8F4724023ADQ35205515-21548CE3-41D7-4FC6-8FC8-EE0B15EDE267Q35271174-F07F78F7-1514-470D-B148-55FCC137550BQ35436209-34CFA5F8-3AE5-4D24-8FA8-0641E73AA296Q35576914-2793553D-D090-4044-A536-9E672A328501Q35598235-762FD1B0-AAF6-4BD3-8B47-96CE5C239F55Q35757910-4955A9B0-881A-44D8-A80D-3D200ED013A5Q36269155-2D7AA8CD-FFBC-429C-950B-5E8017BA8901Q36362257-CAC55038-7CEE-46FB-8E05-2142A774EE3FQ36506158-119C23C7-BE30-4AEB-B0E9-8ECFC93B7811Q36558924-4CE7F1DF-74C1-4084-A02A-10DB4B50B389Q36593894-C9858ABB-717B-4319-89A7-203C57E5C027Q36747225-9DEE2408-7112-4BB8-AC6F-78B71FED03EBQ37287217-B5813D7C-AC1D-4988-8B31-D982C5B7ADF9Q37335500-6994A55A-8328-4E48-AD63-3492960323A9Q37709749-504B3AD1-EB42-4EEE-A5B0-817E6067525FQ37928954-D4A995D1-E8AC-4BDD-A111-668277D3F214Q37965727-C246501B-4E29-43AC-BB81-EF3521FC4F43Q37986492-79E9993F-A340-4F16-A40F-8F9D4801EAAAQ38006998-F497771D-3D82-48F5-81F8-C0AC1AB2A900Q38032878-AC92DC4A-C1C8-43E1-8716-1E2FAE1B0AC8
P2860
Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Analysis of strategies to succ ...... igenic E. coli (ETEC) disease.
@ast
Analysis of strategies to succ ...... igenic E. coli (ETEC) disease.
@en
type
label
Analysis of strategies to succ ...... igenic E. coli (ETEC) disease.
@ast
Analysis of strategies to succ ...... igenic E. coli (ETEC) disease.
@en
prefLabel
Analysis of strategies to succ ...... igenic E. coli (ETEC) disease.
@ast
Analysis of strategies to succ ...... igenic E. coli (ETEC) disease.
@en
P2093
P1433
P1476
Analysis of strategies to succ ...... igenic E. coli (ETEC) disease.
@en
P2093
Ad Hoc ETEC Technical Expert Committee
Duncan Steele
Richard I Walker
Teresa Aguado
P304
P356
10.1016/J.VACCINE.2006.12.028
P407
P577
2006-12-19T00:00:00Z